ライフサイエンスコーパス: developer

1 larvae have no free swimming phases (direct developers).

2 razolium, and 1.9 uM phenazine methosulfate; developer.

3 for both the non-expert user and the methods developer.

4 ed, making SBFC useful to both modellers and developers.

5 eutics, remain formidable challenges to drug developers.

6 rather than the labels generated by ontology developers.

7 notable practical conclusions for users and developers.

8 such as policy makers, funders, and product developers.

9 oping a free-living tadpole quickly in rapid developers.

10 multidisciplinary group of active guideline developers.

11 llowing additional modules to be included by developers.

12 ing used by a number of stochastic simulator developers.

13 ndly environment to both users and algorithm developers.

14 eers, computational scientists, and software developers.

15 ential removal and discussed with the FS-ICU developers.

16 net-based searches; and contact with measure developers.

17 n to the JBrowse genome browser, targeted at developers.

18 through June 1997, produced by 69 different developers.

19 es into explicit recommendations for vaccine developers.

20 et to close the gap between method users and developers.

21 BS v1.1 were scored using ASCO-NHB v2 by its developers.

22 erve as a useful benchmark for HIV-1 vaccine developers.

23 cult for patients, clinicians, and guideline developers.

24 that use data from both indirect and direct developers.

25 es that limit access to a small community of developers(1,2).

26 The data presented here give vaccine developers a "glycosylation target" for their immunogens

27 f cocrystals and offers researchers and drug developers a new analytical tool.

28 ng interface and updating service, and gives developers a toolkit to provide database-searching capab

29 ulating databases; and providing feedback to developers about improved design, performance, and funct

30 Casual users and developers alike will be able to leverage the public RES

31 mmers, amateur programmers, and professional developers alike.

32 d reduce cognitive load for both the initial developer and subsequent contributors; this allows devel

33 ic biology communities, including inventors, developers and adopters of Type IIS cloning methods.

34 will provide guidance to future application developers and also articulate the remaining research ch

35 that the GATK programming framework enables developers and analysts to quickly and easily write effi

36 performance estimate is important for method developers and applied researchers.

37 s meet the needs of cancer researchers, drug developers and clinicians interested in personalized med

38 flicts between the interests of tidal energy developers and commercial and recreational users of the

39 lity, so it can be used by a wide variety of developers and computational biologists; development usi

40 Our experience as developers and curators of NeuroMorpho.Org suggests that

41 uence of RGD reaches bioinformaticians, tool developers and curators.

42 on in H. erythrogramma with that in indirect developers and discuss its implications for modularity i

43 dized reporting template is proposed to help developers and evaluators of IHC applications conduct ev

44 Thus, the survey will help tool designers/developers and experienced end users understand the unde

45 e a meeting of malaria researchers, database developers and genomics scientists, and to discuss how g

46 t has good external validity among guideline developers and good interrater reliability across traine

47 rease international cooperation between drug developers and health-care providers adopting new regime

48 These results can aid guideline developers and laboratory directors who are considering

49 applications that incurs negligible cost to developers and lowers barriers to Rosetta use for the br

50 fies for policy makers, funders, and vaccine developers and manufacturers the potential impact of eff

51 Forum (NQF) guidelines is to provide measure developers and other stakeholders with guidance on the s

52 cal Ontologies (NCBO) (a joint effort of OBO developers and OWL experts) and offers options to ease t

53 ering chemical noise from the polymer or the developers and plasticizers used in the fabrication proc

54 AI developers and policy makers need to devise methods of c

55 lay an important role in informing guideline developers and policy makers.

56 indings are timely and important for vaccine developers and policy-makers alike.

57 scientific communities, including individual developers and projects, through major service providers

58 lished literature, consultation with vaccine developers and regulatory agencies, and a collaborative

59 Developers and sponsors of these candidate products were

60 tive feedback was gathered from intervention developers and the general public to improve the utility

61 of Rosetta has largely remained confined to developers and their immediate collaborators due to the

62 Both developers and users of AI toolsneed a better understand

63 In addition, it is relevant to developers and users of gene function prediction methods

64 ative, this community study, comprising both developers and users of glycoproteomics software, evalua

65 g and releasing reagents that can be used by developers and users of microfluidics for their specific

66 results may provide valuable insight to both developers and users of prediction methods.

67 BOSC offers a focused environment for developers and users to interact and share ideas about s

68 alyses and give recommendations for software developers and users to reduce the risk of such errors.

69 ta set is publicly and freely available, and developers and vendors of CO-from-ABP algorithms are inv

70 systematic reviewers, and clinical guideline developers), and patient representatives developed the C

71 systematic reviewers, and clinical guideline developers), and patient representatives produced the CO

72 l decision-makers (i.e., local government, a developer, and homebuyers) and fiscal drivers (e.g., pro

73 Major advances by investigators, vaccine developers, and affected communities are revealing new i

74 to annotation providers, prediction software developers, and end-users, who all need to assess what i

75 biomedical research community, therapeutics developers, and health care delivery enterprises will ul

76 Health care providers, guideline developers, and policymakers are often unsure which mode

77 onsiderable attention from researchers, drug developers, and regulatory agencies.

78 butes to the needs of policy makers, donors, developers, and researchers for economic assessments of

79 serverification' protocol for use by Rosetta developers, and the deployment of the first nine ROSIE a

80 n rations are nutritionally complete, ration developers are challenged to improve palatability to pro

81 Malaria vaccine developers are concerned that antigenic escape will erod

82 in the Internet laboratory, researchers and developers are creating a variety of autonomous economic

83 All prediction tool developers are invited to participate in the benchmark.

84 The pharmaceutical and biotechnology developers are now challenged to find their own pragmati

85 Software developers are often open about the code they produce an

86 However, significant challenges faced by developers as a product moves from the purely theoretica

87 3Dmol.js provides a full featured API for developers as well as a straightforward declarative inte

88 a result, EVA provides useful information to developers as well as users of prediction methods.

89 dorsement of these DDTs is critical for drug developers, as it promotes confidence in their use in In

90 threshold that should be applied when method developers assess the performance of their novel multiva

91 This lets RNA-seq methods developers assess their procedures in non-ideal (model-v

92 Among 268 developers assessed, 20 large firms accounted for 80.8%

93 erMine is a fully extensible framework where developers can add new tools and functionality.

94 ing bias so that policy makers and guideline developers can base their recommendations on the appropr

95 Using this method, assay developers can calculate statistically valid limits of d

96 An additional feature is that developers can directly investigate any hydrophobicity s

97 Developers can embed libSBML in their applications, savi

98 By following these suggestions, developers can ensure that they use high quality raw and

99 t categories correlate with vulnerabilities, developers can implement more effective security measure

100 with the help of bottlenecks we have found, developers can improve the current tools or build new on

101 Tool developers can now easily share their tools with proteom

102 With little effort, developers can plug their own algorithms into the OSCAR

103 By following this protocol, tool developers can provide a uniform UI regardless of the PT

104 Conversely, developers can submit their workflows to myExperiment an

105 Plugin developers can take advantage of the existing user-inter

106 ient formats and a web service that software developers can use to conveniently query and access all

107 The critical insights on the developer, commercial brand name, detection methods, tec

108 Support is available from an active user and developer community and also on a commercial basis.

109 tion (CAMI) challenge has engaged the global developer community to benchmark their programs on highl

110 ta for testable hypotheses, and those in the developer community who wish to build tools that leverag

111 influenced the growth of the BioJS user and developer community, and outline our strategy for buildi

112 cortex and anterior cingulate cortex in the developers compared with healthy control subjects and re

113 Guideline developers considered clinical evidence, health economic

114 s to report observed outputs of concern, the developers did not respond when observations of vulnerab

115 Developer documentation and a wide range of example simu

116 ration is needed between radiologists and AI developers due to the overreliance on art and photograph

117 interest to neuroscientists as well as drug developers due to their exquisite potency and selectivit

118 tery, comprising tests from independent test developers each with their own set of norms, facilitates

119 vement professionals, information technology developers, educators, administrators, and practitioners

120 Direct-developers exhibit the slowest rates of evolution and th

121 t, and whichever technology is used, vaccine developers face several challenges linked to the particu

122 onsidering the history of game projects in a developer firm, we see that adding diversity first, and

123 This platform lets developers focus on designing algorithms and biologists/

124 barcoding cases, and can also be extended by developers for custom needs or for the integration of ne

125 jamborees, genome comparison and for use by developers for rapid feedback during annotation software

126 sistence of the software is compromised when developers graduate, funding ceases, or investigators tu

127 The SBOL Developers Group has implemented SBOL as an XML/RDF seri

128 ic distribution of gene lengths while slower developers have an expanded number of long genes.

129 Env is highly glycosylated, and yet vaccine developers have lacked guidance on how to assess whether

130 Relatively few public database developers have the resources to implement sophisticated

131 d offer significant relief, although vaccine developers have warned that design, testing and producti

132 require coordinated efforts among technical developers, health care providers, and regulatory bodies

133 of synthetic and analytical chemists, assay developers, high-throughput screening and automation eng

134 ries and specification documentation to help developers implement SBOL in their own software.

135 The optimal concentration of radiolabeled developer in the test is dependent upon a balance of the

136 BPA is used as a developer in thermal paper products, including cash regi

137 This method could be a pioneer developer in TU sensitive chemical sensor development us

138 This study can assist clinicians and drug developers in deciding which theranostic targets should

139 searchers, reviewers, readers, and guideline developers in how to use them to assess risk of bias and

140 what is to be considered atypical can guide developers in recognizing and reacting to abnormal behav

141 enactable techniques can assist intervention developers in selecting appropriate self-directed techni

142 tions from researchers, software and methods developers in structural sciences, data repository provi

143 , and between young early readers and normal developers, in amplitude envelope onset detection.

144 fluenced early life history traits: offshore developers initially grew slowly but compensated with fa

145 w opportunity comes a challenge for software developers: instead of rewriting our software applicatio

146 antify photoresist/photoacid and photoresist/developer interactions on the fidelity of lithographic f

147 ic digestion, thus could help biogas project developers investigate similar scale scenarios .

148 The growing number of docking developers is engaged in the community-wide assessments

149 ensive ecosystem, bringing together software developers, language engineers and research staff from d

150 predefined positivity cutoffs by each assay developer/manufacturer).

151 Furthermore, software developers may download a Perl package that includes met

152 non-programmers and a set of libraries that developers may use to convert between various proteomics

153 national group that included experienced COS developers, methodologists, journal editors, potential u

154 ND An international group of experienced COS developers, methodologists, journal editors, potential u

155 tandard techniques for comparing alignments, Developer, Modeler and Total Column (TC) scores can be d

156 Without such standards, tool developers must account for a variety of annotation form

157 swer questions in very specialized contexts, developers must also provide software libraries that emp

158 ing internal or external validity, guideline developers must assess the robustness of recommendations

159 (MSD) scenario introduces an impact fee that developers must pay if they choose not to use LID to bui

160 rable areas now being actively considered by developers, nearly half the turbines in a farm are likel

161 Clinicians and software developers need to understand how proposed machine learn

162 ructured nature of the data, as noted by its developers, nor can it be tractably run on the full RNAC

163 A thorough assessment will allow developers not only to select suppliers who comply with

164 The focus for vaccine developers now moves to the next generation of malaria v

165 .com/aresio/cupSODA (requires an Nvidia GPU; developer.nvidia.com/cuda-gpus).

166 In the 1890s, Siegfried Czapski, the developer of the Carl Zeiss corneal biomicroscope, the d

167 acilitate interactions between users and the developer of the database.

168 or machine learning algorithm favored by the developer of the GEP test employed in this study, 9 of t

169 faster, and offers more flexibility for the developers of algorithms for raw data analysis.

170 ves of academic researchers and of prominent developers of anaerobic technology.

171 nt with single-cell and bulk samples so that developers of analysis methods can assess accuracy and p

172 possibilities may benefit clinicians and the developers of antibody-based therapies and vaccines.

173 s and from six of eight large pharmaceutical developers of anticancer drugs.

174 synthesis and drug discovery as well as from developers of asymmetric catalysts.

175 h we exemplify can be readily adopted by the developers of bioinformatics resources.

176 eatments suffers similar challenges faced by developers of conventional antibiotics; however, most of

177 we detail these and other challenges facing developers of cortical visual prostheses in addition to

178 discuss several challenges and solutions for developers of COVID-19-related guidelines and recommenda

179 d extent is important for database curators, developers of function annotation programs, and anyone w

180 a detailed description to current and future developers of how each of these noncanonical backbones w

181 g gas-phase ion chemistry could be useful to developers of in silico programs for fragmentation predi

182 Developers of innovative drugs have to blaze a new path

183 Developers of machines with similar capacities should pr

184 he implementation of lipid name handling for developers of mass spectrometry-based lipidomics tools,

185 ge of sizes and materials that appeal to the developers of microfluidic devices.

186 We encourage developers of new algorithms to submit their routines to

187 A rapid test was established to give developers of new drugs in the preclinical stage the opp

188 o evaluate binding site predictions, both by developers of new methods and by the assessors for the c

189 and the email and co-commit networks between developers of open source software.

190 The PRO Consortium works in concert with the developers of other biomedical ontologies and protein kn

191 omic alternative to commercial equipment for developers of paper-based devices.

192 ng MR methodologists, MR study design users, developers of previous reporting guidelines, and journal

193 hemists, including structural biologists and developers of protein pharmaceuticals.

194 ance of current mapping software, we invited developers of RNA-seq aligners to process four large hum

195 different methods is beneficial both for the developers of scaffold assembly algorithms and for the r

196 rectly informs decision makers and guideline developers of the robustness of treatment recommendation

197 , rapid DST will need to be prioritised, but developers of these assays will need better data about t

198 As the developers of these packages optimize their algorithms w

199 ental knowledge and industrial firms as mere developers of university research.

200 mendations for experimentalists and software developers of what constitutes a solid lipid identificat

201 archers, clinicians, policy makers, and test developers on optimal clinical and operational character

202 te the community of duckweed researchers and developers on the progress in the field.

203 taries, and input from publication guideline developers; ongoing review of the literature on the epis

204 Specifically, should drug developers optimize therapeutics and formulations to inc

205 For algorithm developers, OSCAR is a plug-and-play platform.

206 antities of clinical text to researchers and developers outside of major medical centers.

207 for new oncology products with the needs of developers, payers, physicians and patients.

208 lot project, neurophysiologists and software developers produced a common data format for recordings

209 to find and install apps they need and help developers promote their apps.

210 Here, vaccine developers provide synopses of their candidate vaccines

211 slated into products that benefit healthcare developers, providers or consumers.

212 rce international collaboration of volunteer developers, providing Python libraries for a wide range

213 ght the intrinsic complexities faced by drug developers pursuing histology-agnostic therapeutic agent

214 of commercial model deprecation that balance developers' reasonable interest in restricting access to

215 overers (reported DEB at baseline only), and developers (reported DEB at follow-up only).

216 arate efforts to make optimal use of limited developer resources and maximize the curation output.

217 n be improved and propose checklists to help developers, reviewers, and scientists to assess the qual

218 original institution or even off the primary developer's computer.

219 Researchers and developers seeking to refine simulation tools or develop

220 chmark for gene finding and, therefore, most developers select their own benchmarking strategy.

221 treatment options are available, guidelines developers should consider network meta-analysis.

222 gastrointestinal epithelial infections, drug developers should consider the adverse impact of active

223 c life histories to Bd and found that direct developers showed more rapid increases in infection load

224 interest to the community of researchers and developers since it hides the complications of software

225 irst nine ROSIE applications by six separate developer teams: Docking, RNA de novo, ERRASER, Antibody

226 After consensus with the developers, ten items were dropped (and 24 were retained

227 al Network (G-I-N) is a network of guideline developers that includes 93 organizations and 89 individ

228 st 62 (threshold determined by the AI system developers), therefore resulting in the highest examinat

229 ient progress with AI assistance, and the AI developer to receive continuous feedback from both the p

230 stable application programming interface for developers to add additional protocols, (c) a flexible b

231 urce data management platform, which enables developers to add functionalities.

232 available in C++ and Java) makes it easy for developers to add SBGN support to their tools, whereas t

233 Given the fast market growth, attention of developers to ARM chipsets and Android/iOS is warranted,

234 It also allows method developers to assess their own algorithms and compare th

235 quality measures that allow users as well as developers to benchmark and compare their map alignment

236 r their experiments, allows 3D SMLM software developers to benchmark new software against the current

237 A webtool was made available for developers to benchmark their procedures.

238 Analysing more diverse metrics can enable developers to better understand user engagement, justify

239 The system makes it easy for developers to both compare the overall performance of th

240 , as having a validation framework helps (1) developers to build new software, (2) research scientist

241 this work will help formulators and product developers to choose the right buffer and emulsifier com

242 per and subsequent contributors; this allows developers to concentrate on core functionality and redu

243 powerful extension systems that allows other developers to contribute additional functionality in for

244 ods, and we encourage a broader community of developers to contribute to this growing resource.

245 hics into their usual analysis pipelines, 2) developers to create additional complex and interactive

246 base into a modular, extensible platform for developers to create and deploy all-new visualizations o

247 ing how we evaluate software, we can empower developers to create tools that more effectively acceler

248 benchmark provides a framework for users and developers to document the precision of new applications

249 Carbon crediting mechanisms allow project developers to earn carbon credits through mitigation pro

250 This helps ontology developers to efficiently create, maintain, and release

251 standard interfaces and protocols that allow developers to encapsulate information tools as services

252 o provide a means of communication with test developers to ensure that fit-for-purpose DSTs are being

253 b Service interfaces, and allows application developers to focus on the scientific tool and workflow

254 These changes present a need for vaccine developers to identify Env variants with epitopes most l

255 Our reference data sets enabled developers to improve their software tools.

256 ingococcal disease is sufficient for vaccine developers to incorporate serogroup Y into new vaccines.

257 This allows developers to integrate additional third-party programs

258 t system is a middleware that allows service developers to integrate tools based on existing and emer

259 th the hope that it will spur other software developers to make their CLIM applications available ove

260 We outline practical recipes for resource developers to maximize the research impact of data shari

261 ns for users when choosing packages, and for developers to maximize the usefulness of their contribut

262 classic ImageJ interface, allowing users and developers to migrate to these new methods at their own

263 ccess software components to enable software developers to more effectively mine the PDB archive and

264 or patients to combine data that allows drug developers to query against and compensate patients for

265 Its high-level functionality enables developers to quickly prototype ideas for computational

266 Automatic code allows developers to quickly write VBS data analysis scripts an

267 Easy-to-use APIs are available for developers to reuse and extend Web3DMol.

268 We then asked developers to run their software on our data; most respo

269 ls developed in this manuscript enable assay developers to screen appropriate, low-fluorescence porou

270 cal industry, pressure is increasing on drug developers to take more seriously the sustainability ram

271 major depressive disorder submitted by drug developers to the FDA between 1979 and 2016, comprising

272 esults, we encourage bioinformatics software developers to use an ordering based on a universal hitti

273 rovements, if they can be made, will require developers to work with more comprehensive predictor set

274 ge management system that allows third party developers to write additional functionality that can be

275 The BrAPI specification and the developer tools are provided as free and open source.

276 the strengths of web technologies (SVG, D3, developer tools) so that visualizations can be rapidly a

277 tal health advocates, dog lovers, video game developers, vegans, bitcoin investors, conspiracy theori

278 In collaboration with the software developers, we evaluated OpenSWATH, SWATH 2.0, Skyline,

279 For tool developers, we focus on characterizing five distinct pro

280 ical practice guideline databases, guideline developer Web sites, and published health literature ide

281 n extensive help file and tool-tips, and the developers welcome user suggestions.

282 The slow developers were Epipedobates machalilla and Epipedobates

283 Effect sizes were reduced when the slowest developers were excluded, but many effects remained sign

284 on subsequent educational attainment (later developers were less likely to progress beyond basic edu

285 d 11 minimum standards to be followed by COS developers when planning their projects and by users whe

286 ach set of predictions are also provided for developers, which comply with the Critical Assessment of

287 utions from a growing, international team of developers who not only maintain compatibility with SBML

288 Third-party developers wishing to create new tools can use the API t

289 s; hence SEBINI should be useful to software developers wishing to evaluate, compare, refine or combi

290 The SAT will provide developers with a complete package which will save time

291 on in 2000, BOSC has provided bioinformatics developers with a forum for communicating the results of

292 open and easy to reproduce format, providing developers with a framework for future comparisons again

293 from existing models to provide intervention developers with a greater chance of producing an interve

294 e easy to install and use by novice database developers with a minimal amount of computer expertise.

295 n, compared to the alternative of recruiting developers with already existing cross-gender ties.

296 Many animals are indirect developers with distinct larval and adult body plans [1]

297 missions and controls can assist biorefinery developers with the air permitting process and inform re

298 the pipeline for user training tutorials and developer work.

299 Accordingly, these developers would benefit from a reusable toolkit of user

300 While developers would still need to implement an independent